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motoneuron hyperexcitability in amyotrophic lateral sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) is a type of motor neuron disease (MND) in which humans lose motor
functions due to progressive loss of motoneurons in the cortex, brainstem, and spinal cord. In patients and in
animal models of MND it has been observed that there is a change in the properties of motoneurons, termed
neuronal hyperexcitability, which is an exaggerated response of the neurons to a stimulus. Previous studies
suggested neuronal excitability is one of the leading causes for neuronal loss, however the factors that instigate
excitability in neurons over the course of disease onset and progression are not well understood, as these
studies have looked mainly at embryonic or early postnatal stages (pre-symptomatic). As hyperexcitability is
not a static phenomenon, the aim of this study was to assess the overall excitability of upper motoneurons
during disease progression, specifically focusing on their oscillatory behavior and capabilities to fire
repetitively. Our results suggest that increases in the intrinsic excitability of motoneurons are a global
phenomenon of aging, however the cellular mechanisms that underlie this hyperexcitability are distinct in
SOD1 G93A ALS mice compared with wild-type controls. The ionic mechanism driving increased excitability
involves alterations of the expression levels of HCN and KCNQ channel genes leading to a complex dynamic
of H-current and M-current activation. Moreover, we show a negative correlation between the disease onset
and disease progression, which correlates with a decrease in the expression level of HCN and KCNQ
channels. These findings provide a potential explanation for the increased vulnerability of motoneurons to
ALS with aging.
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Abstract
Amyotrophic lateral sclerosis (ALS) is a type of motor neuron disease (MND) in which humans lose motor functions
due to progressive loss of motoneurons in the cortex, brainstem, and spinal cord. In patients and in animal models of
MND it has been observed that there is a change in the properties of motoneurons, termed neuronal hyperexcitability,
which is an exaggerated response of the neurons to a stimulus. Previous studies suggested neuronal excitability is one
of the leading causes for neuronal loss, however the factors that instigate excitability in neurons over the course of
disease onset and progression are not well understood, as these studies have looked mainly at embryonic or early
postnatal stages (pre-symptomatic). As hyperexcitability is not a static phenomenon, the aim of this study was to
assess the overall excitability of upper motoneurons during disease progression, specifically focusing on their
oscillatory behavior and capabilities to fire repetitively. Our results suggest that increases in the intrinsic excitability of
motoneurons are a global phenomenon of aging, however the cellular mechanisms that underlie this hyperexcitability
are distinct in SOD1G93A ALS mice compared with wild-type controls. The ionic mechanism driving increased
excitability involves alterations of the expression levels of HCN and KCNQ channel genes leading to a complex dynamic
of H-current and M-current activation. Moreover, we show a negative correlation between the disease onset and
disease progression, which correlates with a decrease in the expression level of HCN and KCNQ channels. These
findings provide a potential explanation for the increased vulnerability of motoneurons to ALS with aging.
Introduction
Motor neuron disease and excitability
Amyotrophic lateral sclerosis (ALS) is the most pre-
valent form of motor neuron disease (MND) and is
characterized by a progressive loss of both upper and
lower motor neurons, leading to paralysis and ultimately
death due to a respiratory failure, often within 3–5 years
from diagnosis. In the absence of a unifying mechanism
that leads to the clinical symptoms, multiple processes
have been found to be instrumental in disease progres-
sion. One of the most prominent changes in MND
patients is an increased excitability of motoneurons,
leading to fasciculation, cramps, hyperreflexia, and spas-
ticity in MND patients1. Due to these symptoms, it has
been hypothesized that neuronal hyperexcitability medi-
ated by glutamate excitotoxicity is a leading cause for
neuronal loss during MND, reviewed by ref. 2. However,
recent studies have challenged this concept, questioning
the impact of increased cellular excitability on neuronal
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survival3, and influence on excitability symptoms4,5.
Moreover, recent in vivo studies showed that adult spinal
motoneurons are not hyperexcitable6, and that fast fatig-
able lower motoneurons, which are most vulnerable in
amyotrophic lateral sclerosis mouse models, display
hypoexcitability and loss of repetitive firing rather than
hyperexcitability prior to degeneration7.
SOD1 mouse model
Familial ALS (fALS) accounts for approximately 5–10%
of all ALS cases. The first discovery linked to fALS was a
mutation in the ubiquitously expressed Cu–Zn super-
oxide dismutase (SOD1) enzyme, which catalyzes the
dismutation of superoxide anions (O2
−) to oxygen and
H2O2
8. Indeed, mutant SOD1 has been found to cause
malfunction of many cellular pathways and processes,
including excitotoxicity and mitochondrial stress, which
leads to cell death9. Identification of SOD1 mutations in
ALS led to the development of several mouse models,
including a transgenic mouse that expresses multiple
copies of a mutated form of human SOD1 (SOD1G93A),
and that develops a progressive ALS with many simila-
rities to the human disease10.
Aims of study
Neuronal excitability is not a static phenomenon but
rather shows a pattern of progression in a spatiotemporal
aspect1, in which the biophysiological properties of
motoneurons change with age. Therefore, it is essential to
distinguish between physiological alterations in cellular
excitability that are simply due to normal aging and
alterations that are caused by the progression of the dis-
ease. Previous studies examining hyperexcitability in ALS
mouse models have used mainly embryonic or early
postnatal stage neurons, which has made it difficult to
assess the role of hyperexcitability in normal aging.
Hence, the aim of this study was to monitor the physio-
logical properties of upper motoneurons during aging, as
well as in different stages of the disease, which is crucial
for our understanding of the mechanisms leading to
motoneuron degeneration.
Results
To assess cellular alterations occurring during the
progression of ALS, we recorded the electrophysiological
properties of upper motoneurons (UMNs) residing in
layer 5b of the motor cortex of transgenic mice expressing
the mutated human SOD1 gene (SOD1G93A) and their
wildtype littermate controls10. Mice were divided into two
different age groups, corresponding to definite disease
stages. The first group consisted of SOD1 mice at the age
of 70–80 days (average of 73 ± 1 days). Although previous
reports indicate that these mice show cellular differences
as early as a few days3,11, our mouse colony at this age
were still lacking behavioral phenotypes or any motor
dysfunction, so we named them the ‘Young SOD1′ group
(n= 19). The second group, ‘Aged SOD1′ were SOD1
mice at the age of 5–7 months, which showed symptoms
of ALS (Symptomatic group, n= 55), including rigid
paralysis and minimal joint movement of the limbs, cor-
responding to neurological score (NS) 2 as described by
refs. 12,13. As controls for normal aging, we used age-
matched littermates named ‘Young Control’ (n= 21) and
‘Aged Control’ (n= 53), which neither express the mutant
human SOD1 enzyme, nor show any symptoms.
Characteristics of our mouse colony
Our mouse colony consisted of 55 symptomatic mice,
28 males and 27 females. While the average age in which
females started showing deterioration in motor function
(NS 1; corresponding to motor weakness—depicted as
partial collapse of leg extension or trembling of hind legs
during tail suspension) was 147 ± 4 days, the males started
showing symptoms at the age of 155 ± 5 days (Fig. 1a). On
average, SOD1 mice reached NS 2 after 168 ± 2 days, (no
significant differences between genders, student t-test),
which is longer than the period of 17–20 weeks published
in previous reports10,14. Moreover, the deterioration rate
from the first onset of the symptoms until the mice
reached NS 2 was longer than previously described,
averaging 21 ± 2 days in females and 22 ± 3 days in males
(Fig. 1b). These alterations in motor function were
accompanied with weight loss (Fig. 1c), as previously
described by other studies12,14.
Intriguingly, there was a moderate negative correlation
between the disease onset (the age at which the mice first
showed symptoms of motor impairment (NS 1)) and the
duration in which the mice stayed at the NS 1 phase
before progressing to NS 2 (Fig. 1d). These changes in
disease progression from previous studies are most likely
attributed to a decrease in the relative copy number of the
expressed human SOD1 transgene, (6.2 ± 0.2, see12)
compared with the original SOD1G93A mouse line10,15
that reportedly had a gene copy number of 18 ± 2.6.
Cortical motoneurons from symptomatic SOD1 mice are
hyperexcitable
To assess alterations in the intrinsic properties of cor-
tical motorneurons during disease progression, we have
recorded the passive and active electrophysiological
properties of pyramidal neurons residing in layer 5b of the
primary motor cortex (M1). Layer 5 pyramidal neurons
are heterogenous and consist of various types of moto-
neurons, including corticospinal and corticostriatal
motoneurons, which display different electrophysiological
properties16–19. Two of the most prominent features of
corticospinal neurons are their distinct laminar location
in layer 5b of the motor cortex and relatively high Sag
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amplitude, ranging from 10 to 40%, as previously reported
by refs. 16–19. Although previous reports showed that the
overall excitability profile of all cortical neurons increased
in SOD1 mice4,20, to reduce bias selection of the recorded
neurons, only pyramidal neurons residing in layer 5b and
expressing a Sag amplitude higher than 10% were inclu-
ded in the analysis (Supplementary Fig. 1). The impact of
aging and SOD1 mutation on cortical motoneuron
excitability was assessed using two-way analysis of var-
iance (ANOVA), followed by a Tukey’s post hoc test.
Table 1 summarizes the significant impact of aging, the
SOD1 mutation and the interaction between these factors,
on the intrinsic membrane properties of cortical
motoneurons.
On average, the resting membrane potential of layer 5b
pyramidal neurons recorded from the primary motor cor-
tex (M1) was comparable between all groups tested (p >
0.05; two-way ANOVA, Fig. 2b). Conversely, the excit-
ability of pyramidal neurons from aged SOD1 symptomatic
mice was higher than young SOD1 pre-symptomatic mice,
depicted as a significant decrease (F(1,65)= 40.93, P < 0.0001
for the factor aging and F(1, 65)= 4.586, P < 0.01 for the
factor interactions, two-way ANOVA) in the spike rheo-
base (from 136 ± 15 pA to 80 ± 10 pA; n= 22 and 24,
respectively, p < 0.01, two-way ANOVA with Tukey’s post
hoc test; Fig. 2c) and a trend for increased input resistance
(from 193 ± 21MΩ in ‘Young SOD1′ to 218 ± 30MΩ in
‘Aged SOD1′; Fig. 2d). The increase in cellular excitability
was also significant in age-matched controls, as the rheo-
base significantly decreased from 161 ± 18 pA (n= 12) in
the ‘Young control’ group to 48 ± 17 pA in the ‘Aged
control’ group (n= 11, F(1, 65)= 4.586, p < 0.001, two-way
ANOVA with Tukey’s post hoc test). However, closer
investigation into the relationship between the rheobase
current and the overall input conductance suggested that
the excitability profile of cortical motoneurons was higher
in the SOD1 mice than their aged-matched controls
(depicted as a lower gain of slope, Fig. 2e, f), indicating an
impactful involvement of the SOD1 mutation, which
interacts with normal aging (Table 1).
Neuronal spiking activity is determined by a complex
interaction of voltage dependent inward and outward
currents, and underlies the execution of neuronal output
which contributes significantly to network behavior21. As
muscle movement is defined by the firing rate of moto-
neurons, and one of the hallmarks of ALS is a loss of the
ability of lower motoneurons to fire repetitively6,7, we
measured the firing frequency-current (F-I) curves
Fig. 1 Assessment of motor function in SOD1 mice colony. a Bar graph depicting the average age in which SOD1 symptomatic mice showed
deterioration in motor function (NS 1 according to criteria outlined by the ALS therapy Development Institute). b Bar graph depicting the average
duration of SOD1 males and females at the NS 1 phase. c A plot depicting the change in body weight (for both males and females) as a percentage
of the body weight measured on the first day of disease onset. Data in a–c is presented as mean ± S.E.M. d Plot of the duration at NS 1 phase vs the
age of disease onset depicting moderate negative correlation. The fitted regression line is shown with 95% mean prediction interval
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(Fig. 3a–c), as well as the oscillatory behavior (Fig. 4) of
cortical motoneurons. Our results showed that the aver-
age gain of the spiking F-I curves of motoneurons from
symptomatic “aged SOD1” mice was significantly higher
(F(1, 57)= 9.442, P < 0.001, two-way ANOVA) than pre-
symptomatic “young SOD1” motoneurons (0.09 ± 0.01
Hz/pA, n= 21 vs. 0.05 ± 0.01 Hz/pA, n= 21 respectively;
p < 0.05; two-way ANOVA with Tukey’s post hoc test;
Fig. 3c, d), indicating an increased excitability and ability
to fire at higher frequencies. However, there was a trend
for an increase in the average gain of F-I curves recorded
from aged controls compared with young controls
(Fig. 3b), though this did not reach statistical significance.
Neurons act as resonators that on the one hand respond
preferentially to inputs at a certain frequency, and on the
other affect the network oscillatory activity22. Neuronal
resonance frequency is determined by the interplay of
passive and active properties23,24, mainly slowly activating
K+ current and a fast-persistent Na+ current25, and
affects spike propagation and adaptation23. Our results
Fig. 2 Intrinsic membrane properties of upper motoneurons displaying increased excitability with age. a Image of recorded motoneuron
filled with biocytin during intracellular recording. Scale bar= 40 μm. b–d Box plots depicting the distribution of the resting membrane potential
(RMP; b), rheobase (c) and input resistance (d) of cortical motoneurons recorded from both SOD1 mice (Young and Aged, coded in blue) and age
matched controls (black). The box upper and lower limits are the 25th and 75th quartiles, respectively. The whiskers depicting the lowest and highest
data points, while the+ sign represents the mean and the horizontal line through the box is the median. Both ‘aged SOD1′ and age matched control
mice express a significant decrease in spike rheobase, indicating a global phenomenon occurring during normal aging (black asterisks above the
dashed line). e, f Scatter plots depicting the relationship between the rheobase current and the overall input conductance in the different groups.
Each plot was fitted with a linear regression line. The gain of each slope (M) defines the overall excitability profile for each group, indicating an
enhanced excitability of SOD1 mice compared to their age matched controls. Asterisks above the dashed line in c and d represent the significance
levels of the impact of “Age” (black), ‘SOD1 Mutation’ (blue) and level of interaction (red). Asterisks below the dashed line represent significance levels
between groups following Tukey’s post hoc test. *p < 0.05; **p < 0.005; ***p < 0.001; ****p < 0.0001, two-way ANOVA
Table 1 Age and SOD1 mutation affects the intrinsic properties of cortical motoneurons
Rin Rheobase Sag amplitude mAHP HCN1 HCN2 HCN3 KCNQ2 KCNQ3 KCNQ5
Aging * **** **** ** **** ** *
SOD1 Mutation *** *** * * ** ** **
Interaction * *
Intrinsic properties of cortical motoneurons change during normal aging and are affected by the SOD1 mutation. Significance levels presented as *p < 0.05, **p <
0.005, ***p < 0.001, ****p < 0.0001; Reported P-values are by two-way ANOVA with factors ‘age’ (black asterisks), ‘SOD1 mutation’ (blue asterisks) and interaction
between factors (red asterisks)
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show that the average resonance frequency of the cortical
motoneurons recorded remained stable and neither
change due to normal aging nor during disease progres-
sion (Fig. 4a, b).
In order to evaluate the relationship between membrane
oscillation frequencies and spike threshold, we injected
sinusoidal currents at different intensities (30–250 pA
chirp current) at increasing frequencies (0.1–100 Hz;
Fig. 4c). This protocol detects neuronal excitability at
instantaneous sinusoidal frequencies and allows an eva-
luation of the relationship between neuronal excitability
and oscillatory behavior, depicted by the Frequency-
Spiking Curve (SFC, Fig. 4d, e). Analysis of the sinusoidal
frequency curves of upper motoneurons suggest that
following low amplitude sinusoidal stimulation (≤125 pA),
motoneurons from both ‘aged control’ mice and ‘aged
SOD1′ symptomatic mice were able to fire action
potentials at higher oscillations frequencies than young
mice (7.8 ± 2.3 Hz (n= 8) and 8.5 ± 1.4 Hz (n= 23) vs. 1.8
± 0.8 Hz (n= 12) and 3.7 ± 0.8 Hz (n= 22), respectively;
U= 17, p < 0.01 for control and U= 128, p < 0.001 for
SOD1, Mann-Whitney’s two-tailed U-test, Fig. 4d, e).
However, no significant alterations were identified at
higher amplitudes (>125 pA), indicating a differential
impact of aging on the maximal firing frequency.
Moreover, no differences were observed between the gain
of SFCs recorded from SOD1 mice and their age-matched
controls (Fig. 4f). Together these results suggest that the
intrinsic alterations controlling the maximal frequency at
which neurons were still able to fire action potentials,
were limited to lower spiking frequencies and were simply
due to the physiological impact of aging.
Cortical neurons lose their capability of repetitive firing in
pre-symptomatic stages
Previous reports suggested that in ALS, neurons lose
their capability of repetitive firing, and once symptoms of
ALS appear, a substantial amount of motoneurons may
have already degenerated26. This implies that most neu-
ronal death occurs during the pre-symptomatic stages and
progress with time. For this reason, we compared the
spiking activity of all pyramidal neurons recorded in layer
5 of the motor cortex. In order to assess neuronal firing
patterns, we injected increasing step currents greater than
>150% of rheobase amplitude. All recorded upper moto-
neurons from young controls showed repetitive firing
(Fig. 5a), however 23.0% of upper motoneurons recorded
from the ‘young SOD1′ pre-symptomatic mice, lost their
capability of repetitive firing. In comparison, only 7.9% of
neurons from the ‘aged SOD1′ symptomatic group lost
Fig. 3 Cortical motoneurons are hyperexcitable in SOD1 symptomatic mice. a Representative voltage traces of action potentials evoked by
injections of increasing step currents into the soma of cortical motoneurons. b, c Plots of the spike frequency-current relationship (F-I curves)
measured from littermate controls (b) and SOD1 mice (c) depicting alterations of the spiking trajectories, indicating hyperexcitability of motoneurons
recorded from the ‘aged control’ and ‘aged SOD1′ symptomatic group, compared to motoneurons recorded from the ‘Young control’ and ‘Young
SOD1′ pre-symptomatic mice respectively. d Bar graph depicting the average gain of F-I curves in the different groups. Note the significant impact of
aging (asterisk above dash line, two-way ANOVA) on the overall increase in F-I gain, indicative of increased excitability. *p < 0.05; Asterisk below
dashed line represent significance levels between groups using Tukey’s post hoc test. Box plots definition are the same as in Fig. 2
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their capability of repetitive firing, while 21.4% of aged
controls showed similar features (Fig. 5a). This suggests
that at least two-thirds of the neurons that had lost their
ability to fire repetitively in the pre-symptomatic stage
had been lost by the symptomatic stage of the disease.
Further analysis of the spiking properties showed that
while the spike amplitude and spike width at half ampli-
tude (SWHA) were similar among all groups (Fig. 5b, c),
the medium after hyperpolarization (mAHP; Fig. 5d),
which is mediated by small conductance potassium
channels27, as well as muscarinic and HCN channels28,29,
increased significantly from 2.5 ± 0.4 mV (n= 10) in ‘aged
control’ mice to 4.5 ± 0.5 mV (n= 24) in ‘aged SOD1′
symptomatic mice (F(1,60)= 6.15, p < 0.05; two-way
ANOVA followed by Tukey’s post hoc test, Fig. 5e).
This increase was absent in young mice, suggesting it is
specifically attributed to the disease progression in
SOD1 symptomatic mice (F(1,60)= 6.15, P < 0.05, two way
ANOVA).
To assess the ionic mechanisms underlying the altera-
tions in neuronal firing patterns and mAHP we measured
the impact of H-current (Ih) and M-current (Im) on
neuronal excitability during disease progression. The H-
current is activated by hyperpolarization of the resting
membrane potential and mediated by hyperpolarization-
activated cyclic nucleotide-gated (HCN) channels, which
are permeable for both Na+ and K+ ions and therefore
have an equilibrium potential of −30mV. This current
affects the neuron oscillatory activity, responsiveness to
inhibitory synaptic potentials (IPSPs) and resting mem-
brane potential30. Analysis of the hyperpolarization-‘Sag’
amplitude (Fig. 5d), mainly mediated by the H-current
(Ih), identified a significant increase in the Sag amplitude
(F(1,64)= 15.33, P < 0.001, two way ANOVA), which was
mainly caused by aging (Fig. 5f, Table 1). However, an
increase in Ih conductance is usually accompanied by
depolarization of the resting membrane potential and a
decrease in input resistance, which we did not observe
(see Fig. 2), suggesting other processes may be super-
imposing and masking our results. For these reasons, we
repeated the recordings with a selective antagonist of the
non-inactivating K+ channels mediating the M-current
(Im), XE991
31. These recordings indicated a significant
increase in the Sag amplitude and overall excitability of
motoneurons following Im inactivation, across all groups
(p < 0.01, t= 3.22, df= 14 for young SOD1; p < 0.01, t=
27, df= 1 for aged control and p < 0.05, t= 2.57, df= 10
for aged SOD1, two tailed paired student t-test, Fig. 6a).
Fig. 4 Oscillatory behavior of cortical motoneurons. a Impedance amplitude profile depicting the peak resonance frequency of neuron
membrane potential (inset, blue trace) following chirp stimulation (inset, black trace). b Box plots depicting the distribution of the resonance
frequency in all groups tested. c Sample voltage traces recorded following sinusoidal chirp stimulation (0.1–100 Hz) at different intensities (from
bottom to top: 30, 60, 125, 250 pA), which were used to build the sinusoidal-frequency spiking curves. d, e Sinusoidal-frequency curves depicting the
relationship between the oscillation intensity and the maximal frequency at which the cell is still excitable. Note the upward shift in the maximal
oscillation frequency in both aged control (d) and symptomatic mice (e), compared to ‘young control’ and ‘young SOD1′ pre-symptomatic mice
respectively. *p < 0.05; Mann-Whitney test. f Box plots depicting the distribution of the gain of the sinusoidal-frequency curves in all groups tested.
Box plots definition are the same as in Fig. 2
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Moreover, examination of the F-I curves following inhi-
bition of the M-current led to an upward shift of the F-I
curve of motoneurons recorded from both ‘young SOD1′
and ‘aged SOD1′ mice, suggesting enhanced excitability
(Fig. 6b, c). In contrast, application of the Kv7 K+ channel
opener, retigabine, did not affect the F-I curve of moto-
neurons recorded from ‘young SOD1′ pre-symptomatic
mice (Fig. 6b, green markers), yet reduced the excitability
of motoneurons recorded from ‘aged SOD1′ symptomatic
mice (Fig. 6c). The relative change in Sag amplitude fol-
lowing Im inhibition was highest in ‘young SOD1′ pre-
symptomatic mice (average increase of 57 ± 25% com-
pared with 28 ± 17% in ‘aged SOD1′ symptomatic mice),
consistent with the significantly higher expression
levels of KCNQ2 (F (1, 28)= 21.08, P < 0.0001 for aging and
F(1, 28)= 7.64, P < 0.01 for mutation) and KCNQ3 (F (1, 28)
= 11.92, P < 0.001 for aging and F(1, 28)= 10.29, P < 0.001
for mutation) channel genes in the motor cortex of ‘young
SOD1′ mice (compared with symptomatic ‘aged SOD1′
animals; p < 0.05, two way ANOVA with Tukey’s post hoc
test, Fig. 6d). Further analysis of the expression level of
HCN channel genes in the motor cortex of all groups
tested identified a significant decrease of HCN1 channel
expression during both normal aging (F(1, 26)= 33.9,
p < 0.0001, two-way ANOVA) and disease progression
(F(1, 26)= 13.84, p < 0.001, two-way ANOVA, Fig. 6e,
Table 1), yet the expression level in SOD1 mice was sig-
nificantly higher than their littermate controls. Intrigu-
ingly, the expression pattern of HCN1, KCNQ2, and
KCNQ3 channels was similar, depicting a significant
decrease with age, but greater expression in SOD1 mice
(Fig. 6d, e), underpinning the differential impact of Im on
cortical motoneurons during symptomatic and pre-
symptomatic stages. Together our data thus identifies a
complex dynamic between H-current and M-current in
aging and in ALS.
Discussion
ALS is a multi-factorial disease, however increasing
evidence suggests that hyperexcitability, which is thought
to develop in the motor cortex, is the underlying
mechanism leading to loss of motoneurons1,32,33. The
Fig. 5 Motor neurons lose their capability of repetitive firing during pre-symptomatic stages. a Pie chart depicting the portion of neurons that
cannot fire repetitively out of all recorded pyramidal neurons. Sample traces of singular (left) and regular (right) spiking neurons. b, c Box plots
depicting the distribution of the spike amplitude (b) and spike width at half amplitude (SWHA; C) in the different groups. Box plots definition are the
same as in Fig. 2, no significant differences were noted between groups. d Sample traces depicting the mAHP amplitude (left) recorded following
train of action potentials, and Sag amplitude (right) recorded following administration of hyperpolarizing current. e Box plots describing the
distribution of the mAHP, indicating a significant increase in mAHP amplitude of ‘Aged SOD1′ symptomatic mice compared to ‘Young SOD1′ pre-
symptomatic animals, which is due to SOD1 mutation. f Box plots of the Sag amplitude, as indication for Ih conductance, identify significant increase
which is due to aging. Asterisks above the dashed line in e and f represent the significance levels of the impact of “Age” (black) and ‘SOD1 Mutation’
(blue). Asterisks below the dashed line represent significance levels between groups following Tukey’s post hoc test. *p < 0.05; **p < 0.005; ***p <
0.001; two-way ANOVA
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source of cortical hyperexcitability can be either via
alterations in intrinsic properties of upper motoneurons,
extrinsic circuitry processes that affect the inhibition-
excitation balance34, or via modulation of glial activity9,35.
However, a recent study that investigated the correlation
between selective loss of corticospinal neurons and their
excitability showed that alterations in cortical excitability
are not cell-type specific, but rather a global phenomenon
of the motor cortex. Indeed both excitatory and inhibitory
neurons exhibited increases in intrinsic excitability, which
were provisional to the disease stage and counterbalanced
by the cortical circuit4.
Here, we assessed the intrinsic cellular properties of
cortical motoneurons during disease progression in
in vitro slice preparations, which provides mechanical
stability and fine control of the extracellular environment.
Fig. 6 Differential impact of M-current on neuronal excitability. a Bar graph depicting the impact of M-current inhibition (via bath application of
XE991) on the average Sag amplitude. Although the Sag amplitude increased in all groups, the relative average increase in the ‘young SOD1′ pre-
symptomatic group was highest. Data presented as the average % of change of the Sag amplitude recorded prior to application of XE991; *p < 0.05,
paired two tailed student t-test. b, c F–I curves following inhibition (+XE991) or facilitation (+Retigabine) of the M-current in ‘young SOD1′pre-
symptomatic (c) and ‘aged SOD1′ symptomatic (d) mice. Note that facilitation of M-current with retigabine in the pre-symptomatic mice had no
impact on neuronal excitability. d Box plots depicting the distribution of mRNA levels of KCNQ channel genes in the motor cortex normalized to the
housekeeper genes. Expression levels of KCNQ channel genes are significantly higher in the motor cortex of pre-symptomatic ‘Young SOD1′ mice
than symptomatic ‘Aged SOD1′ mice, supporting the relative impact of M-current on the Sag amplitude of pre-symptomatic mice. e Box plots
depicting the distribution of mRNA levels of HCN channel genes in the motor cortex normalized to the housekeeper genes. Box plots definition are
the same as in Fig. 2. Asterisks above the dashed line in d and e represent the significance levels of the impact of “Age” (black) and ‘SOD1 Mutation’
(blue). *p < 0.05; **p < 0.005; ***p < 0.001; ****p < 0.0001, two-way ANOVA
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Our results suggest that alteration of the intrinsic excit-
ability of cortical motoneurons is a characteristic phe-
nomenon of aging in this mouse model, as indicated by
the decrease in spike rheobase in both SOD1 symptomatic
mice and their age-matched controls (Fig. 2c). However,
two-way analysis of variance showed that the SOD1
mutation affects cellular processes that increase the
excitability profile of cortical motoneurons and interact
with normal aging, as summarized in Table 1. Moreover,
the overall increase in excitability of cortical motoneurons
from SOD1 mice suggest that the degree of augmented
excitability is higher in SOD1 mice compared with their
age-matched littermate controls, as indicated by the
declined slope of the rheobase-conductance curves
(Fig. 2e, f).
Neuronal firing properties form the basis for the neural
code, which regulates numerous operations of the central
nervous system, including motor control and complex
cognitive processes36. A key feature of spiking neurons is
their capability to act as resonators that amplify inputs at
certain preferential frequencies, shaping their firing pat-
terns23. The H-current, mediated by hyperpolarization-
activated cyclic nucleotide-gated cation channels, affects
neuron resonance behavior, as well as synaptic and den-
dritic integration, thus regulating spiking output and
overall motor control37. Indeed, computational models
show that enhancement of Ih may control the rate of
rhythmic oscillations in neural networks38, and recent
reports showed that upper motoneurons express high
levels of Ih
19. In that regard, our results indicate that the
expression level of HCN channels was higher in mice
expressing the SOD1 mutation (compared with age-
matched controls, Fig. 6e), which surprisingly was not
accompanied by an increase in the resonance frequency
(Fig. 4b), nor a decrease in the overall input resistance as
might be expected. This counterintuitive result suggests
that the increase in Ih is superimposed with other
mechanisms that mask its function. One candidate that is
active during subthreshold membrane potential is the M-
current, which forms a non-inactivating outward K+
current.
H-current and M-current have biophysiological prop-
erties that counterbalance each other, reviewed by ref. 39.
While activation of Ih leads to membrane depolarization
and increased excitability, activation of M-current, medi-
ated by four subunits of the KV7 (KCNQ) K
+ channel
family40, will do the opposite. In general, we found that
the expression level of HCN1, HCN2, and HCN3 mRNA,
as well as KCNQ2, KCNQ3, and KCNQ5 channels in the
motor cortex decreased with age and disease progression,
yet were higher in SOD1 mice than their age-matched
controls (Fig. 6b, e). Moreover, the expression level of
these channels was gender independent, as no differences
were recorded between males and females.
Our results suggest there is a differential impact of KV7
channel activity during disease progression, as the
increase in the Sag amplitude following Im inactivation
with XE991 was much greater in the ‘young SOD1′ pre-
symptomatic mice than in the symptomatic mice (paired
t-test, Fig. 6a). Hence, these results suggest that the
enhancement of Ih during aging could be caused essen-
tially by reduced activity of KV7 channels (Fig. 6). As both
M-current and H-current are mediated by voltage gated
channels, yet they have different activation curves, this
means that their combined impact on intrinsic excitability
of motoneurons is complex and varies between different
types of neurons and age. While M-current consistently
drives K+ outflow and thus hyperpolarization, once active,
it counterbalances the inward Na+ flow of the Ih cur-
rent39, leading to the low Sag amplitude seen in young
animals (Fig. 5f). Moreover, the reduced M-current in
symptomatic mice (‘Aged SOD1′ compared with pre-
symptomatic ‘Young SOD1′mice) could explain the slight
trend for increased overall input resistance (Fig. 2).
Consistent with our results, Milan and colleagues found a
complex age-related dynamic of the cholinergic system in
the spinal cord that appeared completely disrupted in
SOD1 motoneurons41. Moreover, a recent report showed
that the Kv7 channel activator retigabine, which increases
KV7 channel opening and stabilizes the resting membrane
potential, both blocks the hyperexcitability and improves
motor neuron survival in vitro, when tested in SOD1 ALS
patient motor neurons in cell culture42. Consistent with
this, our results show that application of retigabine had an
inhibitory impact on motoneuron excitability, and a
greater effect on motoneurons in the symptomatic ‘aged
SOD1′ than the pre-symptomatic ‘young SOD1′ mice
(compare 6B and 6C).
Overall, our findings provide insights into the intrinsic
physiological properties of cortical motoneurons under-
lying cortical hyperexcitability, a common phenotype in
MND. Despite controversy as to the underlying
mechanisms leading to cortical hyperexcitability, it is
paramount to emphasize that neuronal intrinsic excit-
ability is not a static phenomenon, and is constantly
changing during normal aging, as well as different
pathologies1. However, the nature of these properties will
determine the transformation of neural signals into active
movement, and knowledge about alterations in these
properties is an essential step in unraveling new ther-
apeutic targets. Moreover, the negative correlation
between disease onset and disease progression (Fig. 1d)
might be due to age-dependent compensatory mechan-
isms for functional motor control, in which the capacity
for compensation decreases with age. This compensatory
mechanism might involve molecular mechanisms that
slow the neurodegenerative process, reviewed by ref. 43, or
recruitment of other neurons leading to a greater
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activation of the network involved in motor control, as
suggested by ref. 44 for Huntington’s disease. Never-
theless, these observations provide insight into potential
therapeutic targets that could alleviate disease symptoms
or progression.
Conclusions
We have identified increased neuronal excitability in
‘normal’ aging in cortical motor neurons and a distinct
mechanism for aberrant hyperexcitability beyond ‘normal’
aging in a mouse model of ALS. These changes are
mediated by a dynamic interplay between H-current and
M-current and provides a potential explanation for
increased vulnerability of motor neurons to ALS with
aging.
Material and Methods
Animals
Transgenic SOD1 mice (SOD1G93A)1Gur/J were ori-
ginally from the colony held by Justin Yerbury (University
of Wollongong, NSW, Australia). Mice were bred and
maintained on the B6SJL background by breeding
mSOD1 transgenic males with non-transgenic females in
a rotational scheme. All animals handled with standard
conditions of temperature, humidity, 12 h light/dark cycle,
free access to food and water, and without any intended
stress stimuli. All experiments were approved and per-
formed in accordance with Western Sydney University
committee for animal use and care guidelines (Animal
Research Authority #A11789).
Slice preparation
Animals were deeply anesthetized by inhalation of iso-
flurane (5%). Following anesthesia, mice were transcar-
dially perfused with ice-cold HEPES-buffered N-methyl
glucamine-artificial cerebrospinal fluid (aCSF) solution
containing in mM: 2.5 KCl; 1.25 NaH2PO4; 25 NaHCO3;
25 D-glucose; 10 MgSO4; 92 NMDG (N-methyl gluca-
mine); 0.5 CaCl2; 20 HEPES; 2 Thiourea; 5 Na-ascorbate;
3 Na-pyruvate (NMDG-ACSF), until the outflow solution
was clear. After perfusion, the mice were decapitated, and
their brains were quickly removed and placed into ice-
cold aCSF containing (in mM): 125 NaCl, 2.5 KCl, 1
MgCl2, 1.25 NaH2PO4, 2 CaCl2, 25 NaHCO3, 25 glucose,
and saturated with carbogen (95% O2–5% CO2 mixture;
pH 7.4). Parasagittal brain slices (300 μm thick) were cut
with a vibrating microtome (Leica VT1200S) and trans-
ferred to the BraincubatorTM (PaYo Scientific, Sydney;
http://braincubator.com.au), as reported previously45. The
Braincubator is an incubation system that closely moni-
tors and controls pH, carbogen flow, and temperature, as
well as irradiating bacteria through a separate UV
chamber46,47. Slices were initially incubated for 12min at
35 °C, after which they were allowed to cool to 15–16 °C
and kept in the BraincubatorTM for at least 30 min before
any measurement48.
Electrophysiological recording and stimulation
The recording chamber was mounted on an Olympus
BX-51 microscope equipped with IR/DIC optics. Follow-
ing incubation in the BraincubatorTM, slices were
mounted in the recording chamber for a minimum of
15min, to allow them to warm upto room tempera-
ture (~22 °C), and were constantly perfused at a rate of
2–3ml/min with carbogenated aCSF, as reported pre-
viously49. Whole-cell intracellular recordings from layer V
pyramidal neurons in the motor cortex were obtained
with patch pipettes (5–7MΩ) containing (in mM): 130 K-
Methansulfate, 10 HEPES, 0.05 EGTA, 7 KCl, 0.5
Na2GTP, 2 Na2ATP, 2 MgATP, 7 phosphocreatine, and
titrated with KOH to pH 7.2 (∼285mOsm). Voltages were
recorded in current clamp mode using a multiclamp 700B
dual patch-clamp amplifier (Molecular Devices), digitally
sampled at 30–50 kHz, filtered at 10 kHz, and analyzed
off-line using pClamp 10 software23. Membrane proper-
ties were obtained before and after bath application of the
KCNQ/Kv7 channel blocker XE991 (3 µM) or the KCNQ/
Kv7 enhancer retigabine (10 µM), as previously reported
31.
Cells were considered stable and suitable for analysis if the
input resistance did not change more than 20% during the
baseline recordings, before any treatment.
The Sag potential was measured following injection of
hyperpolarizing current steps (−50 to −150, 1 s, Fig. 5d)
and determined as the difference between the minimum
peak potential and the steady state potential, as previously
described19,37. Sag potentials were normalized to their
respective peak deflection from resting membrane
potential, and only neurons with Sag potentials greater
than 10% were included in the analysis.
Suprathreshold sinusoidal stimulus protocol
In order to evaluate alterations in suprathreshold
oscillation frequencies under different conditions, 10-s
stimulating protocols of sinusoidal current (chirp stimu-
lation), in which there was a linear increase in the fre-
quency from 0.1 to 100 Hz, were designed at 30, 60, 125,
and 250 pA, using the pClamp 10 software suite (Mole-
cular devices, Sunnyvale, CA).
Spectrum impedance analysis
To measure the resonance frequency of individual
neurons, a 20-s subthreshold sinusoidal current at 10 pA,
with a linear increase in frequency from 0.1 to 20 Hz
(chirp stimulation) was applied through the recording
electrode, as previously described23. The resonance fre-
quency was determined as the peak in the impedance
amplitude profile (ZAP) generated by dividing the Fourier
transforms of the voltage signal by that of the current
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signal, as previously described by ref. 25. The voltage
recordings were recorded in millivolts and the current
signal recorded in picoamps and adjusted accordingly
such that the resulting complex impedance can be mea-
sured in Ohms.
qRT-PCR
Halved mouse motor cortices for qRT-PCR analysis
were stored in 0.5 mL RNAlater Solution (Ambion) at
−80 °C. RNA was extracted using the Qiagen RNeasy Plus
Mini Kit, with tissue samples blotted to remove excess
RNAlater Solution before being snap-frozen in liquid
nitrogen. Tissues were homogenized using a mini-pestle
followed by disruption by passing through a 21 G needle 5
times and extraction as per kit instructions, with RNA
eluted in 30 µL volume. RNA yield was determined using
a NanoDrop 2000/2000c Spectrophotometer (Thermo
Fisher Scientific) and 1 µg of RNA was used per 20 µL
cDNA synthesis reaction, using the Tetro cDNA Synth-
esis Kit (Bioline) with Oligo (dT)18 primer. An equivalent
dilution of RNA was prepared in water and stored at −20 °
C for inclusion in qRT-PCR experiments to assess RNA
preparations for genomic contamination (“no RT” con-
trol). The SensiFAST™ SYBR No-ROX Kit (Bioline) was
employed for qRT-PCR, with 20 µL reactions performed
in triplicate. Intron-spanning primers (Table 2; synthe-
sized by Sigma-Aldrich) were selected from PrimerBank50
or designed in-house and evaluated via BLAST and
Ensembl searches. Reactions contained 0.4 µM final con-
centration of each primer, along with 50 ng of cDNA.
Negative controls included water (NTC) and the “no
reverse transcriptase” RNA samples. Three-step cycling
was carried out on a QuantStudio 5 Real-Time PCR
System (Thermo Fisher Scientific) with conditions of 95 °
C for 2 min, then 40 amplification cycles of 95 °C for 5 s,
57–63 °C (primer-dependent; Table 2) for 10 s, and 72 °C
for 20 s, followed by a single melt cycle of 95 °C for 15 s,
60 °C for 1 min, then increasing to 95 °C at a rate of 0.1 °C/
s. The threshold was automatically set by the QuantStudio
Design and Analysis Software (v1.4.3) and the Ct was
calculated as the average of the three replicates. The Ct
values for transcripts of interest were normalized to the
average of the two reference genes, Ccdc127 and Hprt
(Table 2).
Statistical analysis
Unless stated, data is reported as mean ± S.E.M. Statis-
tical comparisons were performed with Prism 7 (Graph-
Pad Software; San Diego, CA) using two-way ANOVA
followed by Tukey’s post hoc test, or two-tailed paired
student t-test as detailed in the text. Data in figures are
presented in two levels. Asterisks above A dashed line
represent the significance levels of the impact of “Age”
(black), ‘SOD1 Mutation’ (blue), and level of interaction
(red). Asterisks below the dashed line represent sig-
nificance levels between groups following Tukey’s post
hoc test. *p < 0.05; **p < 0.005; ***p < 0.001; ****p < 0.0001.
For the box and whisker plots, the box upper and lower
limits are the 25th and 75th quartiles, respectively. The
whiskers depicting the lowest and highest data points,
while the +sign represents the mean and the horizontal
line through the box is the median. Resonance frequency
analysis was performed using custom code written in
Matlab (Mathworks). Probability values <0.05 were con-
sidered statistically significant.
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